HIGHLIGHTS
- who: Neelima Vidula from the (UNIVERSITY) have published the research: Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer, in the Journal: (JOURNAL) of 27/06/2022
- what: The aim of this study was to explore the potential utility of cfDNA for the identification of patients with MBC with a high risk of developing brain metastases.
SUMMARY
Metastatic breast cancer (MBC) can vary in disease presentation, subtype, and molecular profiles, and these variable features may profoundly impact patient outcomes1-3. Specific genomic predictors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.